The expanded clinical spectrum of deferoxamine retinopathy11The authors have no commercial or proprietary interest in any of the materials noted in this article.
- 1 January 2002
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 109 (1) , 164-171
- https://doi.org/10.1016/s0161-6420(01)00947-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- DeferiproneDrugs, 1999
- Pigment epitheliopathy with serous detachment of the retina following intravenous iron dextranEye, 1992
- Vision and hearing during deferoxamine therapyThe Journal of Pediatrics, 1990
- A Model for Desferrioxamine-Induced Retinopathy Using the Albino RatOphthalmologica, 1990
- Ocular and Auditory Toxicity in Hemodialyzed Patients Receiving DesferrioxamineNephron, 1990
- Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia.Archives of Disease in Childhood, 1988
- Ocular Toxicity after a Single Intravenous Dose of Desferrioxamine in 2 Hemodialyzed PatientsNephron, 1987
- Desferrioxamine Administered Intravenously by Infusion Causes a Reduction in the Electroretinogram in Rabbits Anaesthetized with UrethaneHuman Toxicology, 1986
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- Ocular changes in patients undergoing long-term desferrioxamine treatment.British Journal of Ophthalmology, 1984